Is RDSMY.PK a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

88 people get RDSMY.PK articles and Market Currents by email alert.

Get email alerts on RDSMY.PK »

HEADLINES:

Royal DSM's Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 2
Investment Potential In Pharmaceutical CMO Growth Acceleration
Chemistfrog • Tue, Oct 30, 2012 • 1 Comment
8 Undervalued Healthcare Stocks With Strong Receivable Trends
Kapitall • Thu, Jun 21, 2012
Healthcare Stocks On The Move In A Difficult Market
StockPandit • Wed, Jun 6, 2012 • 6 Comments
5 Rallying Healthcare Stocks With Negative Inventory Trends
Kapitall • Wed, May 30, 2012 • 3 Comments
6 Rallying Healthcare Stocks With Strong Receivable Trends
Kapitall • Mon, May 28, 2012 • 1 Comment
5 Small Caps Trading Near Highs With Strong Sales Trends
Kapitall • Fri, May 18, 2012
Record 1Q Sales: Nerve Regeneration Products Gaining Traction
Cockrell Group • Wed, May 16, 2012
Merger Arbitrage Mondays: May 7, 2012
Asif Suria • Mon, May 7, 2012 • 2 Comments
Best And Worst Performing Stocks On Earnings
Bespoke Investment Group • Sat, May 5, 2012
5 Healthy Dividend Growth Stocks To Cure What Ails Your Portfolio
F.A.S.T. Graphs • Thu, May 3, 2012 • 4 Comments
Kensey Nash Reports Third Quarter Fiscal Year 2012 Financial Results

PR Newswire (May 3, 2012)
Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash

PR Newswire (May 3, 2012)
Kensey Nash Corporation Announces Its Third Quarter Fiscal Year 2012 Earnings Release Date and Teleconference

PR Newswire (Apr 24, 2012)
Kensey Nash Introduces A Novel Biomaterial, Meso BioMatrix™ Acellular Porcine Peritoneum, For Plastic And Reconstructive Surgery

PR Newswire (Apr 24, 2012)
AxoGen's Got Nerve: Noble Financial Initiates With 'Buy' Rating
Cockrell Group • Thu, Apr 19, 2012
Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement

PR Newswire (Mar 16, 2012)
Kensey Nash Corporation Declares a Quarterly Dividend of $0.25 Per Share

PR Newswire (Mar 13, 2012)
Kensey Nash to Present at the Sidoti & Company Sixteenth Annual New York Institutional Investor Forum

PR Newswire (Mar 12, 2012)
Under-Followed Dividend Growth Stocks From The Netherlands
Guraaf • Mon, Mar 12, 2012 • 22 Comments

To learn more about Seeking Alpha Pro, click here.

Kensey Nash, Because Biomaterials Is a Growth Industry
Jim Van Meerten • Fri, Jul 9, 2010 • 1 Comment
Kensey Nash Corporation: What a Difference a Year Makes
Ian Wyatt • Fri, Apr 4, 2008
Kensey Nash: Ramius Capital Nearly Doubles Activist Stake
Lon Juricic • Thu, Aug 30, 2007
Kensey Nash: Ramius Capital Discloses 9.9% Stake, Requests Changes, Tender Offer
Lon Juricic • Tue, Jul 3, 2007

Investment Potential In Pharmaceutical CMO Growth Acceleration
Chemistfrog • Tue, Oct 30, 2012 • 1 Comment
8 Undervalued Healthcare Stocks With Strong Receivable Trends
Kapitall • Thu, Jun 21, 2012
Healthcare Stocks On The Move In A Difficult Market
StockPandit • Wed, Jun 6, 2012 • 6 Comments
5 Rallying Healthcare Stocks With Negative Inventory Trends
Kapitall • Wed, May 30, 2012 • 3 Comments
6 Rallying Healthcare Stocks With Strong Receivable Trends
Kapitall • Mon, May 28, 2012 • 1 Comment
5 Small Caps Trading Near Highs With Strong Sales Trends
Kapitall • Fri, May 18, 2012
Record 1Q Sales: Nerve Regeneration Products Gaining Traction
Cockrell Group • Wed, May 16, 2012
Merger Arbitrage Mondays: May 7, 2012
Asif Suria • Mon, May 7, 2012 • 2 Comments
Best And Worst Performing Stocks On Earnings
Bespoke Investment Group • Sat, May 5, 2012
5 Healthy Dividend Growth Stocks To Cure What Ails Your Portfolio
F.A.S.T. Graphs • Thu, May 3, 2012 • 4 Comments
AxoGen's Got Nerve: Noble Financial Initiates With 'Buy' Rating
Cockrell Group • Thu, Apr 19, 2012
Under-Followed Dividend Growth Stocks From The Netherlands
Guraaf • Mon, Mar 12, 2012 • 22 Comments
Sizing Up The Healthcare Sector's January Dogs
Fredrik Arnold • Tue, Jan 31, 2012 • 5 Comments
12 Recent Buys From Chuck Royce
Insider Monkey • Fri, Jan 20, 2012
18 Small Cap Healthcare Stocks For A January Bounce
Alan Brochstein • Tue, Dec 27, 2011 • 5 Comments
Investing For Income In International Dividend Stocks: The Dutch Edition
Retracement • Thu, Sep 22, 2011 • 27 Comments
4 Healthcare Stocks With Positive Correlation To Market Volatility
Kapitall • Tue, Sep 20, 2011
Tough To Find Economic Moats In Chemistry Stocks
Morningstar • Thu, Sep 1, 2011 • 2 Comments
Finding Some Help in the Healthcare Sector
M. E. Garza • Fri, Jul 29, 2011 • 3 Comments
M&A Watch: 8 Medical Consumables Companies That Look Like Buyout Targets
Alan Brochstein • Sun, Oct 11, 2009 • 16 Comments

Royal DSM's Management Discusses Q1 2013 Results - Earnings Call Transcript
Thu, May 2
Kensey Nash Corporation CEO Discusses F1Q2011 Results - Earnings Call Transcript
Thu, Oct 21, 2010
Royal DSM CEO Discusses Q2 2010 Results - Earnings Call Transcript
Mon, Aug 30, 2010
Kensey Nash CEO Discusses F4Q10 Results - Earnings Call Transcript
Mon, Aug 23, 2010
Kensey Nash Corporation F3Q10 (Qtr End 03/31/10) Earnings Call Transcript
Sat, Apr 24, 2010
Kensey Nash Corporation F4Q09 (Qtr End 06/30/09) Earnings Call Transcript
Thu, Aug 20, 2009
Kensey Nash Corporation F3Q09 (Qtr End 3/31/09) Earnings Call Transcript
Wed, Apr 22, 2009
Kensey Nash Corporation F2Q09 (Qtr End 12/31/08) Earnings Call Transcript
Wed, Jan 28, 2009
Kensey Nash Corp. F1Q09 (Qtr End 09/30/08) Earnings Call Transcript
Thu, Oct 23, 2008
Kensey Nash Corp. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript
Thu, Aug 21, 2008
Kensey Nash Corporation Q3 2008 Earnings Call Transcript
Tue, Apr 29, 2008
Kensey Nash Corporation F2Q08 (Qtr End 12/31/07) Earnings Call Transcript
Fri, Jan 25, 2008

Kensey Nash Reports Third Quarter Fiscal Year 2012 Financial Results

PR Newswire (May 3, 2012)
Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash

PR Newswire (May 3, 2012)
Kensey Nash Corporation Announces Its Third Quarter Fiscal Year 2012 Earnings Release Date and Teleconference

PR Newswire (Apr 24, 2012)
Kensey Nash Introduces A Novel Biomaterial, Meso BioMatrix™ Acellular Porcine Peritoneum, For Plastic And Reconstructive Surgery

PR Newswire (Apr 24, 2012)
Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement

PR Newswire (Mar 16, 2012)
Kensey Nash Corporation Declares a Quarterly Dividend of $0.25 Per Share

PR Newswire (Mar 13, 2012)
Kensey Nash to Present at the Sidoti & Company Sixteenth Annual New York Institutional Investor Forum

PR Newswire (Mar 12, 2012)
Kensey Nash Corporation Announces Its Second Quarter Fiscal Year 2012 Earnings Release Date and Teleconference

PR Newswire (Jan 17, 2012)
Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share

PR Newswire (Jan 3, 2012)
Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes

PR Newswire (Dec 16, 2011)
Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation

PR Newswire (Dec 12, 2011)

RDSMY.PK vs. ETF Alternatives

Company Description

Currently, there's no company description for RDSMY.PK.

Sector: Industrial Goods

Industry: Chemicals - Major Diversified

Country: Netherlands

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 3, 2012, 10:50 AM Kensey Nash (KNSY) surges 32% to $38.33, nearing the $38.50/share that Royal DSM (RDSMY.PK) is paying for the medical-device company. Comment! [On the Move, M&A, Healthcare]
Thursday, May 3, 2012, 10:14 AM Kensey Nash (KNSY): FQ3 EPS of $0.34 misses by $0.01. Revenue of $69.3M (+19.4% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
Thursday, May 3, 2012, 9:00 AM Premarket gainers: KNSY +32%. CXW +10%. APKT +7%. ONNN +6%. CLUU +5%. WFM +4%. ARNA +4%. RIG +4%. VIA +3%. TDC +3%. AMT +3%. JRCC +3%. COCO +3%. BUD +3%.
Losers: GMCR -41%. WTW -15%. ATML -8%. NMM -6%. JDSU -4%. TRS -5%. ARO -4%. HT -4%. M -3%. MGM -3%. Comment! [On the Move]
Thursday, May 3, 2012, 2:28 AM Kensey Nash (KNSY), a medical-device company focused on regenerative medicine, agrees to be bought by Royal DSM (RDSMY.PK) for $38.50/share, more than a 30% premium to Kensey Nash's close yesterday. (PR) Comment! [Healthcare, M&A]
Monday, March 19, 2012, 2:13 PM Kensey Nash (KNSY +24%) jumps after saying it's reached a settlement with St. Jude Medical (STJ -0.6%), resolving its dispute regarding vascular closure device licenses and related claims. Under the deal, St. Jude will pay Kensey $39 million over several quarters. Comment! [Healthcare, On the Move]
Thursday, February 2, 2012, 7:33 AM Kensey Nash (KNSY): FQ2 EPS of $0.51 beats by $0.05. Revenue of $23M (+32.2% Y/Y) misses by $0.5M. (PR) Comment! [Earnings, Healthcare]
Friday, December 16, 2011, 2:38 PM Kensey Nash (KNSY -22%) tanks hard, hitting fresh year lows after saying it is lowering its guidance due to a dispute with St Jude Medical (STJ -1.8%) over royalty rates. Comment! [Healthcare, On the Move]
Friday, December 16, 2011, 7:58 AM Kensey Nash (KNSY) agrees to enter mediation with St. Jude Medical (STJ) over royalty payments it says it's owed tied to the Angio-Seal vascular closure device. Shares halted premarket. Comment! [Healthcare]
Tuesday, December 29, 2009, 5:20 PM The quants at Credit Suisse identify 24 Buffett-esque stocks: AFAM, AMGN, APEI, ATRI, AZZ, BKE, BUCY, BYI, CHD, EME, ENSG, JNJ, JOSB, KNSY, LINC, NPK, PETS, POWL, ROST, SCL, TJX, TNDM, VAR, WMS. 2 Comments

Asif Suria
New Post: Merger Arbitrage Mondays http://bit.ly/st1w3P $SUN $GPRO $PLXT $IPSU $PSS $PFCB $CEBK $ESIC $CHRS $SMSC $RDSMY.PK $ABVA $BAMM
5/7/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Asif Suria
Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash $RDSMY.PK http://bit.ly/JF17O1
5/3/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Dividend Sheet
The Best Healthcare Dividend Stocks With Fastest Earnings Growth + http://bit.ly/z4QIpy + $GSK $VIVO $NVS $RDSMY.PK $PETS $ABT $JNJ $LNCR
2/2/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jim Van Meerten
RDSMY.PK - 100% Barchart technical buy signal - 7 new highs and up 18.04% in the last month - Relative strength Index 74.71% and risng
8/18/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
13 Stocks Ready for the Short Squeeze http://ow.ly/5MUkv AAON BBX CALM CVBF HEI RDSMY.PK MCBC PMFG QDEL SCHL TCBI TCBK UBFO
7/25/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

J St. Georges
The eternal recurrence of the same http://bit.ly/h3Xdgu/ $DY, $AVGO, $HEI, $RDSMY.PK
5/25/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Alex B. Gray
Kensey Nash Corp. $RDSMY.PK reported FY2011 Q1 total revenue decreased 14% to $17M and royalty income of $6.1M versus $6.3M in FY2010.
10/21/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Alan Brochstein
I booted RDSMY.PK off my watchlist and added INT. Interesting outsourcing play...
9/23/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jim Van Meerten
RDSMY.PK - Kensey Nash - 40% Barchart short term sell signal - lost in last 2 weeks - trading below its 2 day moving average
7/15/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Jim Van Meerten
RDSMY.PK -Kensey Nash-96% Barchart buy signal with Wall Street recommending buy to their clients based on double digit 5 year EPS growth rates
7/8/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

RDSMY.PK Royal DSM NV

RDSMY.PK

Royal DSM NV